Atossa Therapeutics Inc (NASDAQ:ATOS)

2.43
Delayed Data
As of Sep 18
 +0.11 / +4.74%
Today’s Change
0.76
Today|||52-Week Range
5.08
+54.78%
Year-to-Date
Atossa's COVID-19 nasal spray receives second positive safety review
Sep 17 / Seeking Alpha - Paid Partner Content
Atossa files for $100M mixed shelf
Sep 02 / Seeking Alpha - Paid Partner Content
SRNE, IMGN among premarket gainers
Sep 17 / Seeking Alpha - Paid Partner Content
WDAY, ULTA among premarket gainers.
Aug 28 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close2.32
Today’s open2.34
Day’s range2.33 - 2.54
Volume8,247
Average volume (3 months)824,977
Market cap$25.3M
Data as of 3:55pm ET, 09/18/2020

Growth & Valuation

Earnings growth (last year)+63.14%
Earnings growth (this year)+28.57%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.78

Competitors

 Today’s
change
Today’s
% change
MTPMidatech Pharma PLC-0.06-3.00%
CYANCyanotech Corp0.000.00%
----
----
Data as of 3:54pm ET, 09/18/2020

Financials

Next reporting dateNovember 17, 2020
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$0.00
Annual profit (last year)-$17.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Seattle, Washington

Forecasts